These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 19264847)

  • 1. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
    Ye CG; Wu WK; Yeung JH; Li HT; Li ZJ; Wong CC; Ren SX; Zhang L; Fung KP; Cho CH
    Cancer Lett; 2011 May; 304(2):90-6. PubMed ID: 21377266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
    Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
    Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide induces epithelium- and prostaglandin E(2)-dependent relaxation of mouse isolated trachea through activation of cyclooxygenase (COX)-1 and COX-2.
    Balzary RW; Cocks TM
    J Pharmacol Exp Ther; 2006 May; 317(2):806-12. PubMed ID: 16464966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
    Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
    Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
    Zrieki A; Farinotti R; Buyse M
    Eur J Pharmacol; 2010 Jun; 636(1-3):189-97. PubMed ID: 20361960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
    Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
    Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
    Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
    Ferrera P; Arias C
    Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
    Narang VS; Pauletti GM; Gout PW; Buckley DJ; Buckley AR
    Chemotherapy; 2007; 53(3):210-7. PubMed ID: 17356269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs.
    Angelini A; Iezzi M; Di Febbo C; Di Ilio C; Cuccurullo F; Porreca E
    Oncol Rep; 2008 Oct; 20(4):731-5. PubMed ID: 18813811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CC 05, a novel anti-inflammatory compound, exerts its effect by inhibition of cyclooxygenase-2 activity.
    Yin LL; Zhang WY; Li MH; Shen JK; Zhu XZ
    Eur J Pharmacol; 2005 Sep; 520(1-3):172-8. PubMed ID: 16168408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
    Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
    Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.